{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:51:12Z","timestamp":1790326272528,"version":"4.1.0"},"reference-count":175,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:00:00Z","timestamp":1546560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Research Foundation of Korea (NRF) grant","award":["2017R1A2B2005350"],"award-info":[{"award-number":["2017R1A2B2005350"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s11064-018-02712-1","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T02:11:56Z","timestamp":1546567916000},"page":"735-750","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Therapeutic Effect of Agmatine on Neurological Disease: Focus on Ion Channels and Receptors"],"prefix":"10.1007","volume":"44","author":[{"given":"Sumit","family":"Barua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Youl","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6203-7413","authenticated-orcid":false,"given":"Jong Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,4]]},"reference":[{"key":"2712_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/bs.apcsb.2015.10.006","volume":"103","author":"P Kumar","year":"2016","unstructured":"Kumar P, Kumar D, Jha SK, Jha NK, Ambasta RK (2016) Ion channels in neurological disorders. Adv Protein Chem Struct Biol 103:97\u2013136","journal-title":"Adv Protein Chem Struct Biol"},{"key":"2712_CR2","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.1038\/cddis.2011.112","volume":"2","author":"D Bano","year":"2011","unstructured":"Bano D, Zanetti F, Mende Y, Nicotera P (2011) Neurodegenerative processes in Huntington\u2019s disease. Cell Death Dis 2:e228","journal-title":"Cell Death Dis"},{"key":"2712_CR3","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.2174\/0929867321666131228204246","volume":"21","author":"VS Kumar","year":"2014","unstructured":"Kumar VS, Gopalakrishnan A, Naziroglu M, Rajanikant GK (2014) Calcium ion-the key player in cerebral ischemia. Curr Med Chem 21:2065\u20132075","journal-title":"Curr Med Chem"},{"key":"2712_CR4","first-page":"597","volume":"3","author":"NA Shirwany","year":"2007","unstructured":"Shirwany NA, Payette D, Xie J, Guo Q (2007) The amyloid beta ion channel hypothesis of Alzheimer\u2019s disease. Neuropsychiatry Dis Treat 3:597\u2013612","journal-title":"Neuropsychiatry Dis Treat"},{"key":"2712_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/aps.2012.95","volume":"34","author":"NL Weilinger","year":"2013","unstructured":"Weilinger NL, Maslieieva V, Bialecki J, Sridharan SS, Tang PL, Thompson RJ (2013) Ionotropic receptors and ion channels in ischemic neuronal death and dysfunction. Acta Pharmacol Sin 34:39\u201348","journal-title":"Acta Pharmacol Sin"},{"key":"2712_CR6","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1074\/jbc.M704704200","volume":"283","author":"D Lim","year":"2008","unstructured":"Lim D, Fedrizzi L, Tartari M, Zuccato C, Cattaneo E, Brini M, Carafoli E (2008) Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease. J Biol Chem 283:5780\u20135789","journal-title":"J Biol Chem"},{"key":"2712_CR7","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.bbadis.2012.07.004","volume":"1822","author":"VM Vitvitsky","year":"2012","unstructured":"Vitvitsky VM, Garg SK, Keep RF, Albin RL, Banerjee R (2012) Na+ and K+ ion imbalances in Alzheimer\u2019s disease. Biochim Biophys Acta 1822:1671\u20131681","journal-title":"Biochim Biophys Acta"},{"key":"2712_CR8","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1093\/hmg\/11.20.2435","volume":"11","author":"CA Hubner","year":"2002","unstructured":"Hubner CA, Jentsch TJ (2002) Ion channel diseases. Hum Mol Genet 11:2435\u20132445","journal-title":"Hum Mol Genet"},{"key":"2712_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1006\/exnr.2001.7746","volume":"171","author":"OS Gorbatyuk","year":"2001","unstructured":"Gorbatyuk OS, Milner TA, Wang G, Regunathan S, Reis DJ (2001) Localization of agmatine in vasopressin and oxytocin neurons of the rat hypothalamic paraventricular and supraoptic nuclei. Exp Neurol 171:235\u2013245","journal-title":"Exp Neurol"},{"key":"2712_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0165-6147(00)01460-7","volume":"21","author":"DJ Reis","year":"2000","unstructured":"Reis DJ, Regunathan S (2000) Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci 21:187\u2013193","journal-title":"Trends Pharmacol Sci"},{"key":"2712_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1515\/bchm2.1910.66.3.257","volume":"66","author":"A Kossel","year":"1911","unstructured":"Kossel A (1911) \u00dcber das agmatin. Z Physiol Chem 66:257\u2013261","journal-title":"Z Physiol Chem"},{"key":"2712_CR12","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1126\/science.7906055","volume":"263","author":"G Li","year":"1994","unstructured":"Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ (1994) Agmatine: an endogenous clonidine-displacing substance in the brain. Science 263:966\u2013969","journal-title":"Science"},{"key":"2712_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1749-6632.1995.tb32418.x","volume":"763","author":"G Li","year":"1995","unstructured":"Li G, Regunathan S, Reis DJ (1995) Agmatine is synthesized by a mitochondrial arginine decarboxylase in rat brain. Ann N Y Acad Sci 763:325\u2013329","journal-title":"Ann N Y Acad Sci"},{"key":"2712_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1172\/JCI118430","volume":"97","author":"MJ Lortie","year":"1996","unstructured":"Lortie MJ, Novotny WF, Peterson OW, Vallon V, Malvey K, Mendonca M, Satriano J, Insel P, Thomson SC, Blantz RC (1996) Agmatine, a bioactive metabolite of arginine. Production, degradation, and functional effects in the kidney of the rat. J Clin Investig 97:413\u2013420","journal-title":"J Clin Investig"},{"key":"2712_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-8993(97)01200-6","volume":"787","author":"K Otake","year":"1998","unstructured":"Otake K, Ruggiero DA, Regunathan S, Wang H, Milner TA, Reis DJ (1998) Regional localization of agmatine in the rat brain: an immunocytochemical study. Brain Res 787:1\u201314","journal-title":"Brain Res"},{"key":"2712_CR16","doi-asserted-by":"publisher","first-page":"e66735","DOI":"10.1371\/journal.pone.0066735","volume":"8","author":"D Peters","year":"2013","unstructured":"Peters D, Berger J, Langnaese K, Derst C, Madai VI, Krauss M, Fischer KD, Veh RW, Laube G (2013) Arginase and arginine decarboxylase\u2014where do the putative gate keepers of polyamine synthesis reside in rat brain? PLoS ONE 8:e66735","journal-title":"PLoS ONE"},{"key":"2712_CR17","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.neures.2005.05.002","volume":"52","author":"AR Askalany","year":"2005","unstructured":"Askalany AR, Yamakura T, Petrenko AB, Kohno T, Sakimura K, Baba H (2005) Effect of agmatine on heteromeric N-methyl-D-aspartate receptor channels. Neurosci Res 52:387\u2013392","journal-title":"Neurosci Res"},{"key":"2712_CR18","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1203\/00006450-200210000-00023","volume":"52","author":"Y Feng","year":"2002","unstructured":"Feng Y, Piletz JE, Leblanc MH (2002) Agmatine suppresses nitric oxide production and attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res 52:606\u2013611","journal-title":"Pediatr Res"},{"key":"2712_CR19","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1097\/BRS.0b013e318205e3f7","volume":"36","author":"JH Kim","year":"2011","unstructured":"Kim JH, Lee YW, Park YM, Park KA, Park SH, Lee WT, Lee JE (2011) Agmatine-reduced collagen scar area accompanied with surface righting reflex recovery after complete transection spinal cord injury. Spine 36:2130\u20132138","journal-title":"Spine"},{"key":"2712_CR20","doi-asserted-by":"publisher","first-page":"E87","DOI":"10.1097\/TA.0b013e31820932e2","volume":"71","author":"JR Kuo","year":"2011","unstructured":"Kuo JR, Lo CJ, Chang CP, Lin KC, Lin MT, Chio CC (2011) Agmatine-promoted angiogenesis, neurogenesis, and inhibition of gliosis-reduced traumatic brain injury in rats. J Trauma 71:E87\u2013E93","journal-title":"J Trauma"},{"key":"2712_CR21","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1042\/BCJ20170007","volume":"474","author":"G Laube","year":"2017","unstructured":"Laube G, Bernstein HG (2017) Agmatine: multifunctional arginine metabolite and magic bullet in clinical neuroscience? Biochem J 474:2619\u20132640","journal-title":"Biochem J"},{"key":"2712_CR22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.5607\/en.2017.26.6.380","volume":"26","author":"JH Kim","year":"2017","unstructured":"Kim JH, Kim JY, Jung JY, Lee YW, Lee WT, Huh SK, Lee JE (2017) Endogenous agmatine induced by ischemic preconditioning regulates ischemic tolerance following cerebral ischemia. Exp Neurobiol 26:380\u2013389","journal-title":"Exp Neurobiol"},{"key":"2712_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.5115\/acb.2010.43.3.230","volume":"43","author":"CH Mun","year":"2010","unstructured":"Mun CH, Lee WT, Park KA, Lee JE (2010) Regulation of endothelial nitric oxide synthase by agmatine after transient global cerebral ischemia in rat brain. Anat Cell Biol 43:230\u2013240","journal-title":"Anat Cell Biol"},{"key":"2712_CR24","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.drudis.2013.05.017","volume":"18","author":"JE Piletz","year":"2013","unstructured":"Piletz JE, Aricioglu F, Cheng JT, Fairbanks CA, Gilad VH, Haenisch B, Halaris A, Hong S, Lee JE, Li J, Liu P, Molderings GJ, Rodrigues AL, Satriano J, Seong GJ, Wilcox G, Wu N, Gilad GM (2013) Agmatine: clinical applications after 100 years in translation. Drug Discov Today 18:880\u2013893","journal-title":"Drug Discov Today"},{"key":"2712_CR25","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3346\/jkms.2013.28.3.366","volume":"28","author":"SK Seo","year":"2013","unstructured":"Seo SK, Yang W, Park YM, Lee WT, Park KA, Lee JE (2013) Overexpression of human arginine decarboxylase rescues human mesenchymal stem cells against H2O2 toxicity through cell survival protein activation. J Korean Med Sci 28:366\u2013373","journal-title":"J Korean Med Sci"},{"key":"2712_CR26","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.neubiorev.2011.08.006","volume":"36","author":"TI Uzbay","year":"2012","unstructured":"Uzbay TI (2012) The pharmacological importance of agmatine in the brain. Neurosci Biobehav Rev 36:502\u2013519","journal-title":"Neurosci Biobehav Rev"},{"key":"2712_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbamcr.2004.12.004","volume":"1745","author":"C Mayeur","year":"2005","unstructured":"Mayeur C, Veuillet G, Michaud M, Raul F, Blottiere HM, Blachier F (2005) Effects of agmatine accumulation in human colon carcinoma cells on polyamine metabolism, DNA synthesis and the cell cycle. Biochim Biophys Acta 1745:111\u2013123","journal-title":"Biochim Biophys Acta"},{"key":"2712_CR28","first-page":"616","volume":"26","author":"JF Wang","year":"2005","unstructured":"Wang JF, Su RB, Wu N, Xu B, Lu XQ, Liu Y, Li J (2005) Inhibitory effect of agmatine on proliferation of tumor cells by modulation of polyamine metabolism. Acta Pharmacol Sin 26:616\u2013622","journal-title":"Acta Pharmacol Sin"},{"key":"2712_CR29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000188432","volume":"69","author":"M Marx","year":"1995","unstructured":"Marx M, Trittenwein G, Aufricht C, Hoeger H, Lubec B (1995) Agmatine and spermidine reduce collagen accumulation in kidneys of diabetic db\/db mice. Nephron 69:155\u2013158","journal-title":"Nephron"},{"key":"2712_CR30","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1016\/j.visres.2005.07.025","volume":"45","author":"RE Marc","year":"2005","unstructured":"Marc RE, Kalloniatis M, Jones BW (2005) Excitation mapping with the organic cation AGB2+. Vis Res 45:3454\u20133468","journal-title":"Vis Res"},{"key":"2712_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.metabol.2017.11.005","volume":"81","author":"J Benitez","year":"2018","unstructured":"Benitez J, Garcia D, Romero N, Gonzalez A, Martinez-Oyanedel J, Figueroa M, Salas M, Lopez V, Garcia-Robles M, Dodd PR, Schenk G, Carvajal N, Uribe E (2018) Metabolic strategies for the degradation of the neuromodulator agmatine in mammals. Metabolism 81:35\u201344","journal-title":"Metabolism"},{"key":"2712_CR32","doi-asserted-by":"publisher","first-page":"651","DOI":"10.2174\/156802606776894465","volume":"6","author":"SX Cai","year":"2006","unstructured":"Cai SX (2006) Glycine\/NMDA receptor antagonists as potential CNS therapeutic agents: ACEA-1021 and related compounds. Curr Top Med Chem 6:651\u2013662","journal-title":"Curr Top Med Chem"},{"key":"2712_CR33","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2174\/156802606777057562","volume":"6","author":"C Missale","year":"2006","unstructured":"Missale C, Fiorentini C, Busi C, Collo G, Spano PF (2006) The NMDA\/D1 receptor complex as a new target in drug development. Curr Top Med Chem 6:801\u2013808","journal-title":"Curr Top Med Chem"},{"key":"2712_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1124\/pr.109.002451","volume":"62","author":"SF Traynelis","year":"2010","unstructured":"Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62:405\u2013496","journal-title":"Pharmacol Rev"},{"key":"2712_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.nbd.2011.12.051","volume":"46","author":"MK Brittain","year":"2012","unstructured":"Brittain MK, Brustovetsky T, Sheets PL, Brittain JM, Khanna R, Cummins TR, Brustovetsky N (2012) Delayed calcium dysregulation in neurons requires both the NMDA receptor and the reverse Na+\/Ca2+ exchanger. Neurobiol Dis 46:109\u2013117","journal-title":"Neurobiol Dis"},{"key":"2712_CR36","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1126\/science.7522345","volume":"265","author":"Z Huang","year":"1994","unstructured":"Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA (1994) Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265:1883\u20131885","journal-title":"Science"},{"key":"2712_CR37","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/ana.23626","volume":"72","author":"AM Kaindl","year":"2012","unstructured":"Kaindl AM, Degos V, Peineau S, Gouadon E, Chhor V, Loron G, Le Charpentier T, Josserand J, Ali C, Vivien D, Collingridge GL, Lombet A, Issa L, Rene F, Loeffler JP, Kavelaars A, Verney C, Mantz J, Gressens P (2012) Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain. Ann Neurol 72:536\u2013549","journal-title":"Ann Neurol"},{"key":"2712_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.brainres.2010.12.002","volume":"1373","author":"SK Ahn","year":"2011","unstructured":"Ahn SK, Hong S, Park YM, Lee WT, Park KA, Lee JE (2011) Effects of agmatine on hypoxic microglia and activity of nitric oxide synthase. Brain Res 1373:48\u201354","journal-title":"Brain Res"},{"key":"2712_CR39","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.brainres.2006.02.024","volume":"1084","author":"WP Wang","year":"2006","unstructured":"Wang WP, Iyo AH, Miguel-Hidalgo J, Regunathan S, Zhu MY (2006) Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons. Brain Res 1084:210\u2013216","journal-title":"Brain Res"},{"key":"2712_CR40","first-page":"e00350","volume":"8","author":"VV Costa","year":"2017","unstructured":"Costa VV, Del Sarto JL, Rocha RF, Silva FR, Doria JG, Olmo IG, Marques RE, Queiroz-Junior CM, Foureaux G, Araujo JMS, Cramer A, Real A, Ribeiro LS, Sardi SI, Ferreira AJ, Machado FS, de Oliveira AC, Teixeira AL, Nakaya HI, Souza DG, Ribeiro FM, Teixeira MM (2017) N-Methyl-d-aspartate (NMDA) receptor blockade prevents neuronal death induced by Zika virus infection. MBio 8:e00350","journal-title":"MBio"},{"key":"2712_CR41","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1023\/A:1025069407173","volume":"23","author":"MY Zhu","year":"2003","unstructured":"Zhu MY, Piletz JE, Halaris A, Regunathan S (2003) Effect of agmatine against cell death induced by NMDA and glutamate in neurons and PC12 cells. Cell Mol Neurobiol 23:865\u2013872","journal-title":"Cell Mol Neurobiol"},{"key":"2712_CR42","doi-asserted-by":"publisher","first-page":"10584","DOI":"10.1073\/pnas.97.19.10584","volume":"97","author":"CA Fairbanks","year":"2000","unstructured":"Fairbanks CA, Schreiber KL, Brewer KL, Yu CG, Stone LS, Kitto KF, Nguyen HO, Grocholski BM, Shoeman DW, Kehl LJ, Regunathan S, Reis DJ, Yezierski RP, Wilcox GL (2000) Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci USA 97:10584\u201310589","journal-title":"Proc Natl Acad Sci USA"},{"key":"2712_CR43","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nrn2911","volume":"11","author":"GE Hardingham","year":"2010","unstructured":"Hardingham GE, Bading H (2010) Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 11:682\u2013696","journal-title":"Nat Rev Neurosci"},{"key":"2712_CR44","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2741\/710","volume":"6","author":"M Moretti","year":"2014","unstructured":"Moretti M, Matheus FC, de Oliveira PA, Neis VB, Ben J, Walz R, Rodrigues AL, Prediger RD (2014) Role of agmatine in neurodegenerative diseases and epilepsy. Front Biosci 6:341\u2013359","journal-title":"Front Biosci"},{"key":"2712_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1196\/annals.1304.002","volume":"1009","author":"S Regunathan","year":"2003","unstructured":"Regunathan S, Piletz JE (2003) Regulation of inducible nitric oxide synthase and agmatine synthesis in macrophages and astrocytes. Ann N Y Acad Sci 1009:20\u201329","journal-title":"Ann N Y Acad Sci"},{"key":"2712_CR46","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/hipo.22404","volume":"25","author":"AL Jacob","year":"2015","unstructured":"Jacob AL, Weinberg RJ (2015) The organization of AMPA receptor subunits at the postsynaptic membrane. Hippocampus 25:798\u2013812","journal-title":"Hippocampus"},{"key":"2712_CR47","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.neuron.2011.05.038","volume":"71","author":"J Kumar","year":"2011","unstructured":"Kumar J, Schuck P, Mayer ML (2011) Structure and assembly mechanism for heteromeric kainate receptors. Neuron 71:319\u2013331","journal-title":"Neuron"},{"key":"2712_CR48","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.tins.2007.01.006","volume":"30","author":"SJ Liu","year":"2007","unstructured":"Liu SJ, Zukin RS (2007) Ca2+-permeable AMPA receptors in synaptic plasticity and neuronal death. Trends Neurosci 30:126\u2013134","journal-title":"Trends Neurosci"},{"key":"2712_CR49","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1152\/jn.90286.2008","volume":"101","author":"HY Sun","year":"2009","unstructured":"Sun HY, Bartley AF, Dobrunz LE (2009) Calcium-permeable presynaptic kainate receptors involved in excitatory short-term facilitation onto somatostatin interneurons during natural stimulus patterns. J Neurophysiol 101:1043\u20131055","journal-title":"J Neurophysiol"},{"key":"2712_CR50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0168-0102(03)00023-3","volume":"46","author":"T Anzai","year":"2003","unstructured":"Anzai T, Tsuzuki K, Yamada N, Hayashi T, Iwakuma M, Inada K, Kameyama K, Hoka S, Saji M (2003) Overexpression of Ca2+-permeable AMPA receptor promotes delayed cell death of hippocampal CA1 neurons following transient forebrain ischemia. Neurosci Res 46:41\u201351","journal-title":"Neurosci Res"},{"key":"2712_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuron.2004.06.017","volume":"43","author":"S Liu","year":"2004","unstructured":"Liu S, Lau L, Wei J, Zhu D, Zou S, Sun HS, Fu Y, Liu F, Lu Y (2004) Expression of Ca2+-permeable AMPA receptor channels primes cell death in transient forebrain ischemia. Neuron 43:43\u201355","journal-title":"Neuron"},{"key":"2712_CR52","doi-asserted-by":"publisher","first-page":"8013","DOI":"10.1523\/JNEUROSCI.23-22-08013.2003","volume":"23","author":"M Darstein","year":"2003","unstructured":"Darstein M, Petralia RS, Swanson GT, Wenthold RJ, Heinemann SF (2003) Distribution of kainate receptor subunits at hippocampal mossy fiber synapses. J Neurosci 23:8013\u20138019","journal-title":"J Neurosci"},{"key":"2712_CR53","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.neuroscience.2013.01.029","volume":"235","author":"ER Lowry","year":"2013","unstructured":"Lowry ER, Kruyer A, Norris EH, Cederroth CR, Strickland S (2013) The GluK4 kainate receptor subunit regulates memory, mood, and excitotoxic neurodegeneration. Neuroscience 235:215\u2013225","journal-title":"Neuroscience"},{"key":"2712_CR54","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0014-4886(03)00382-0","volume":"184","author":"JY Lee","year":"2003","unstructured":"Lee JY, Kim JH, Palmiter RD, Koh JY (2003) Zinc released from metallothionein-iii may contribute to hippocampal CA1 and thalamic neuronal death following acute brain injury. Exp Neurol 184:337\u2013347","journal-title":"Exp Neurol"},{"key":"2712_CR55","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.conb.2006.05.004","volume":"16","author":"S Kwak","year":"2006","unstructured":"Kwak S, Weiss JH (2006) Calcium-permeable AMPA channels in neurodegenerative disease and ischemia. Curr Opin Neurobiol 16:281\u2013287","journal-title":"Curr Opin Neurobiol"},{"key":"2712_CR56","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.euroneuro.2016.03.009","volume":"26","author":"VB Neis","year":"2016","unstructured":"Neis VB, Moretti M, Bettio LE, Ribeiro CM, Rosa PB, Goncalves FM, Lopes MW, Leal RB, Rodrigues AL (2016) Agmatine produces antidepressant-like effects by activating AMPA receptors and mTOR signaling. Eur Neuropsychopharmacol 26:959\u2013971","journal-title":"Eur Neuropsychopharmacol"},{"key":"2712_CR57","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/bja\/81.2.208","volume":"81","author":"H Buerkle","year":"1998","unstructured":"Buerkle H, Yaksh TL (1998) Pharmacological evidence for different alpha 2-adrenergic receptor sites mediating analgesia and sedation in the rat. Br J Anaesth 81:208\u2013215","journal-title":"Br J Anaesth"},{"key":"2712_CR58","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0022-2836(05)80271-2","volume":"213","author":"R Henderson","year":"1990","unstructured":"Henderson R, Baldwin JM, Ceska TA, Zemlin F, Beckmann E, Downing KH (1990) Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J Mol Biol 213:899\u2013929","journal-title":"J Mol Biol"},{"key":"2712_CR59","doi-asserted-by":"publisher","first-page":"23405","DOI":"10.1074\/jbc.274.33.23405","volume":"274","author":"T Salminen","year":"1999","unstructured":"Salminen T, Varis M, Nyronen T, Pihlavisto M, Hoffren AM, Lonnberg T, Marjamaki A, Frang H, Savola JM, Scheinin M, Johnson MS (1999) Three-dimensional models of \u03b12A-adrenergic receptor complexes provide a structural explanation for ligand binding. J Biol Chem 274:23405\u201323413","journal-title":"J Biol Chem"},{"key":"2712_CR60","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1139\/Y10-007","volume":"88","author":"M Boxwalla","year":"2010","unstructured":"Boxwalla M, Matwyshyn G, Puppala BL, Andurkar SV, Gulati A (2010) Involvement of imidazoline and opioid receptors in the enhancement of clonidine-induced analgesia by sulfisoxazole. Can J Physiol Pharmacol 88:541\u2013552","journal-title":"Can J Physiol Pharmacol"},{"key":"2712_CR61","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1179\/174313209X444116","volume":"31","author":"Z Han","year":"2009","unstructured":"Han Z, Xiao MJ, Shao B, Zheng RY, Yang GY, Jin K (2009) Attenuation of ischemia-induced rat brain injury by 2-(-2-benzofuranyl)-2-imidazoline, a high selectivity ligand for imidazoline I2 receptors. Neurol Res 31:390\u2013395","journal-title":"Neurol Res"},{"key":"2712_CR62","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejphar.2011.02.038","volume":"658","author":"JX Li","year":"2011","unstructured":"Li JX, Zhang Y (2011) Imidazoline I2 receptors: target for new analgesics? Eur J Pharmacol 658:49\u201356","journal-title":"Eur J Pharmacol"},{"key":"2712_CR63","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1432-1033.1984.tb08462.x","volume":"144","author":"D Atlas","year":"1984","unstructured":"Atlas D, Burstein Y (1984) Isolation and partial purification of a clonidine-displacing endogenous brain substance. Eur J Biochem 144:287\u2013293","journal-title":"Eur J Biochem"},{"key":"2712_CR64","first-page":"293","volume":"252","author":"I Coupry","year":"1990","unstructured":"Coupry I, Atlas D, Podevin RA, Uzielli I, Parini A (1990) Imidazoline-guanidinium receptive site in renal proximal tubule: asymmetric distribution, regulation by cations and interaction with an endogenous clonidine displacing substance. J Pharmacol Exp Ther 252:293\u2013299","journal-title":"J Pharmacol Exp Ther"},{"key":"2712_CR65","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0014-2999(90)94127-J","volume":"190","author":"R Zonnenchein","year":"1990","unstructured":"Zonnenchein R, Diamant S, Atlas D (1990) Imidazoline receptors in rat liver cells: a novel receptor or a subtype of \u03b12-adrenoceptors? Eur J Pharmacol 190:203\u2013215","journal-title":"Eur J Pharmacol"},{"key":"2712_CR66","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1196\/annals.1304.010","volume":"1009","author":"F Aricioglu","year":"2003","unstructured":"Aricioglu F, Korcegez E, Bozkurt A, Ozyalcin S (2003) Effect of agmatine on acute and mononeuropathic pain. Ann N Y Acad Sci 1009:106\u2013115","journal-title":"Ann N Y Acad Sci"},{"key":"2712_CR67","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.neulet.2003.10.010","volume":"354","author":"F Aricioglu","year":"2004","unstructured":"Aricioglu F, Paul IA, Regunathan S (2004) Agmatine reduces only peripheral-related behavioral signs, not the central signs, of morphine withdrawal in nNOS deficient transgenic mice. Neurosci Lett 354:153\u2013157","journal-title":"Neurosci Lett"},{"key":"2712_CR68","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejphar.2014.02.045","volume":"732","author":"MP Dixit","year":"2014","unstructured":"Dixit MP, Thakre PP, Pannase AS, Aglawe MM, Taksande BG, Kotagale NR (2014) Imidazoline binding sites mediates anticompulsive-like effect of agmatine in marble-burying behavior in mice. Eur J Pharmacol 732:26\u201331","journal-title":"Eur J Pharmacol"},{"key":"2712_CR69","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0028-3908(03)00199-0","volume":"45","author":"S Demehri","year":"2003","unstructured":"Demehri S, Homayoun H, Honar H, Riazi K, Vafaie K, Roushanzamir F, Dehpour AR (2003) Agmatine exerts anticonvulsant effect in mice: modulation by \u03b12-adrenoceptors and nitric oxide. Neuropharmacology 45:534\u2013542","journal-title":"Neuropharmacology"},{"key":"2712_CR70","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1111\/bph.13531","volume":"173","author":"GP Shelkar","year":"2016","unstructured":"Shelkar GP, Gakare SG, Chakraborty S, Dravid SM, Ugale RR (2016) Interactions of nitric oxide with \u03b12-adrenoceptors within the locus coeruleus underlie the facilitation of inhibitory avoidance memory by agmatine. Br J Pharmacol 173:2589\u20132599","journal-title":"Br J Pharmacol"},{"key":"2712_CR71","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/00001756-200203250-00005","volume":"13","author":"AD Zomkowski","year":"2002","unstructured":"Zomkowski AD, Hammes L, Lin J, Calixto JB, Santos AR, Rodrigues AL (2002) Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport 13:387\u2013391","journal-title":"Neuroreport"},{"key":"2712_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2009.03.077","volume":"612","author":"F Li","year":"2009","unstructured":"Li F, Wu N, Su RB, Liu Y, Lu XQ, Li J (2009) Comparison of agmatine with moxonidine and rilmenidine in morphine dependence in vitro: role of imidazoline I1 receptors. Eur J Pharmacol 612:1\u20138","journal-title":"Eur J Pharmacol"},{"key":"2712_CR73","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejphar.2010.03.058","volume":"637","author":"BG Taksande","year":"2010","unstructured":"Taksande BG, Kotagale NR, Patel MR, Shelkar GP, Ugale RR, Chopde CT (2010) Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats. Eur J Pharmacol 637:89\u2013101","journal-title":"Eur J Pharmacol"},{"key":"2712_CR74","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.neuropharm.2009.06.035","volume":"57","author":"BG Taksande","year":"2009","unstructured":"Taksande BG, Kotagale NR, Tripathi SJ, Ugale RR, Chopde CT (2009) Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine. Neuropharmacology 57:415\u2013424","journal-title":"Neuropharmacology"},{"key":"2712_CR75","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1021\/acsmedchemlett.6b00290","volume":"7","author":"ME Giusepponi","year":"2016","unstructured":"Giusepponi ME, Cifani C, Micioni Di Bonaventura MV, Mattioli L, Hudson A, Diamanti E, Del Bello F, Giannella M, Mammoli V, Paoletti CD, Piergentili A, Pigini M, Quaglia W (2016) Combined interactions with I1-, I2-imidazoline binding sites and \u03b12-adrenoceptors to manage opioid addiction. ACS Med Chem Lett 7:956\u2013961","journal-title":"ACS Med Chem Lett"},{"key":"2712_CR76","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1124\/mol.63.6.1256","volume":"63","author":"R Fredriksson","year":"2003","unstructured":"Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB (2003) The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63:1256\u20131272","journal-title":"Mol Pharmacol"},{"key":"2712_CR77","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nrd4295","volume":"13","author":"AC Kruse","year":"2014","unstructured":"Kruse AC, Kobilka BK, Gautam D, Sexton PM, Christopoulos A, Wess J (2014) Muscarinic acetylcholine receptors: novel opportunities for drug development. Nat Rev Drug Discov 13:549\u2013560","journal-title":"Nat Rev Drug Discov"},{"key":"2712_CR78","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrd2379","volume":"6","author":"J Wess","year":"2007","unstructured":"Wess J, Eglen RM, Gautam D (2007) Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat Rev Drug Discov 6:721\u2013733","journal-title":"Nat Rev Drug Discov"},{"key":"2712_CR79","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-642-23274-9_1","volume":"2012","author":"RM Eglen","year":"2012","unstructured":"Eglen RM (2012) Overview of muscarinic receptor subtypes. Handb Exp Pharmacol 2012:3\u201328","journal-title":"Handb Exp Pharmacol"},{"key":"2712_CR80","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.tips.2008.12.002","volume":"30","author":"PJ Conn","year":"2009","unstructured":"Conn PJ, Jones CK, Lindsley CW (2009) Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders. Trends Pharmacol Sci 30:148\u2013155","journal-title":"Trends Pharmacol Sci"},{"key":"2712_CR81","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000072880","volume":"48","author":"DL Liao","year":"2003","unstructured":"Liao DL, Hong CJ, Chen HM, Chen YE, Lee SM, Chang CY, Chen H, Tsai SJ (2003) Association of muscarinic M1 receptor genetic polymorphisms with psychiatric symptoms and cognitive function in schizophrenic patients. Neuropsychobiology 48:72\u201376","journal-title":"Neuropsychobiology"},{"key":"2712_CR82","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/med.20158","volume":"29","author":"I Peretto","year":"2009","unstructured":"Peretto I, Petrillo P, Imbimbo BP (2009) Medicinal chemistry and therapeutic potential of muscarinic M3 antagonists. Med Res Rev 29:867\u2013902","journal-title":"Med Res Rev"},{"key":"2712_CR83","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1152\/physrev.00015.2008","volume":"89","author":"EX Albuquerque","year":"2009","unstructured":"Albuquerque EX, Pereira EF, Alkondon M, Rogers SW (2009) Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 89:73\u2013120","journal-title":"Physiol Rev"},{"key":"2712_CR84","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0083-6729(09)81012-1","volume":"81","author":"L Zhang","year":"2009","unstructured":"Zhang L, Xiong W (2009) Modulation of the Cys-loop ligand-gated ion channels by fatty acid and cannabinoids. Vitam Horm 81:315\u2013335","journal-title":"Vitam Horm"},{"key":"2712_CR85","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1146\/annurev.pharmtox.47.120505.105214","volume":"47","author":"JA Dani","year":"2007","unstructured":"Dani JA, Bertrand D (2007) Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47:699\u2013729","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2712_CR86","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.brainres.2012.03.064","volume":"1458","author":"F Rode","year":"2012","unstructured":"Rode F, Munro G, Holst D, Nielsen EO, Troelsen KB, Timmermann DB, Ronn LC, Grunnet M (2012) Positive allosteric modulation of \u03b14\u03b22 nAChR agonist induced behaviour. Brain Res 1458:67\u201375","journal-title":"Brain Res"},{"key":"2712_CR87","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1527-3458.2001.tb00196.x","volume":"7","author":"M Li","year":"2001","unstructured":"Li M, Lester HA (2001) Ion channel diseases of the central nervous system. CNS Drug Rev 7:214\u2013240","journal-title":"CNS Drug Rev"},{"key":"2712_CR88","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0163-7258(01)00161-9","volume":"92","author":"MR Picciotto","year":"2001","unstructured":"Picciotto MR, Caldarone BJ, Brunzell DH, Zachariou V, Stevens TR, King SL (2001) Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications. Pharmacol Ther 92:89\u2013108","journal-title":"Pharmacol Ther"},{"key":"2712_CR89","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrd4052","volume":"12","author":"D Wootten","year":"2013","unstructured":"Wootten D, Christopoulos A, Sexton PM (2013) Emerging paradigms in GPCR allostery: implications for drug discovery. Nat Rev Drug Discov 12:630\u2013644","journal-title":"Nat Rev Drug Discov"},{"key":"2712_CR90","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1476-5381.1990.tb14680.x","volume":"99","author":"RH Loring","year":"1990","unstructured":"Loring RH (1990) Agmatine acts as an antagonist of neuronal nicotinic receptors. Br J Pharmacol 99:207\u2013211","journal-title":"Br J Pharmacol"},{"key":"2712_CR91","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/S0024-3205(97)00801-1","volume":"61","author":"F Aricioglu-Kartal","year":"1997","unstructured":"Aricioglu-Kartal F, Uzbay IT (1997) Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats. Life Sci 61:1775\u20131781","journal-title":"Life Sci"},{"key":"2712_CR92","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bbr.2010.04.049","volume":"213","author":"NR Kotagale","year":"2010","unstructured":"Kotagale NR, Taksande BG, Gahane AY, Ugale RR, Chopde CT (2010) Repeated agmatine treatment attenuates nicotine sensitization in mice: modulation by \u03b12-adrenoceptors. Behav Brain Res 213:161\u2013174","journal-title":"Behav Brain Res"},{"key":"2712_CR93","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S0091-3057(02)00774-8","volume":"72","author":"AD Morgan","year":"2002","unstructured":"Morgan AD, Campbell UC, Fons RD, Carroll ME (2002) Effects of agmatine on the escalation of intravenous cocaine and fentanyl self-administration in rats. Pharmacol Biochem Behav 72:873\u2013880","journal-title":"Pharmacol Biochem Behav"},{"key":"2712_CR94","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.pbb.2009.03.009","volume":"92","author":"RB Su","year":"2009","unstructured":"Su RB, Wang WP, Lu XQ, Wu N, Liu ZM, Li J (2009) Agmatine blocks acquisition and re-acquisition of intravenous morphine self-administration in rats. Pharmacol Biochem Behav 92:676\u2013682","journal-title":"Pharmacol Biochem Behav"},{"key":"2712_CR95","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0166-4328(99)00127-8","volume":"107","author":"IT Uzbay","year":"2000","unstructured":"Uzbay IT, Yesilyurt O, Celik T, Ergun H, Isimer A (2000) Effects of agmatine on ethanol withdrawal syndrome in rats. Behav Brain Res 107:153\u2013159","journal-title":"Behav Brain Res"},{"key":"2712_CR96","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0893-133X(00)00245-1","volume":"25","author":"O Yesilyurt","year":"2001","unstructured":"Yesilyurt O, Uzbay IT (2001) Agmatine potentiates the analgesic effect of morphine by an \u03b12-adrenoceptor-mediated mechanism in mice. Neuropsychopharmacology 25:98\u2013103","journal-title":"Neuropsychopharmacology"},{"key":"2712_CR97","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.bbr.2014.01.004","volume":"262","author":"NR Kotagale","year":"2014","unstructured":"Kotagale NR, Walke S, Shelkar GP, Kokare DM, Umekar MJ, Taksande BG (2014) Agmatine attenuates nicotine induced conditioned place preference in mice through modulation of neuropeptide Y system. Behav Brain Res 262:118\u2013124","journal-title":"Behav Brain Res"},{"key":"2712_CR98","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.euroneuro.2013.12.002","volume":"24","author":"BG Taksande","year":"2014","unstructured":"Taksande BG, Kotagale NR, Gawande DY, Bharne AP, Chopde CT, Kokare DM (2014) Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats. Eur Neuropsychopharmacol 24:955\u2013963","journal-title":"Eur Neuropsychopharmacol"},{"key":"2712_CR99","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.neuropharm.2011.12.031","volume":"62","author":"M Moosavi","year":"2012","unstructured":"Moosavi M, Khales GY, Abbasi L, Zarifkar A, Rastegar K (2012) Agmatine protects against scopolamine-induced water maze performance impairment and hippocampal ERK and Akt inactivation. Neuropharmacology 62:2018\u20132023","journal-title":"Neuropharmacology"},{"key":"2712_CR100","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0165-6147(91)90595-J","volume":"12","author":"RW Tsien","year":"1991","unstructured":"Tsien RW, Ellinor PT, Horne WA (1991) Molecular diversity of voltage-dependent Ca2+ channels. Trends Pharmacol Sci 12:349\u2013354","journal-title":"Trends Pharmacol Sci"},{"key":"2712_CR101","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/316440a0","volume":"316","author":"MC Nowycky","year":"1985","unstructured":"Nowycky MC, Fox AP, Tsien RW (1985) Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature 316:440\u2013443","journal-title":"Nature"},{"key":"2712_CR102","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0301-0082(91)90014-R","volume":"36","author":"RH Scott","year":"1991","unstructured":"Scott RH, Pearson HA, Dolphin AC (1991) Aspects of vertebrate neuronal voltage-activated calcium currents and their regulation. Prog Neurobiol 36:485\u2013520","journal-title":"Prog Neurobiol"},{"key":"2712_CR103","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1124\/pr.57.4.5","volume":"57","author":"WA Catterall","year":"2005","unstructured":"Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J (2005) International union of pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 57:411\u2013425","journal-title":"Pharmacol Rev"},{"key":"2712_CR104","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.neuron.2010.08.021","volume":"67","author":"WA Catterall","year":"2010","unstructured":"Catterall WA (2010) Ion channel voltage sensors: structure, function, and pathophysiology. Neuron 67:915\u2013928","journal-title":"Neuron"},{"key":"2712_CR105","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.nbd.2010.08.020","volume":"41","author":"TS Anekonda","year":"2011","unstructured":"Anekonda TS, Quinn JF, Harris C, Frahler K, Wadsworth TL, Woltjer RL (2011) L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer\u2019s disease. Neurobiol Dis 41:62\u201370","journal-title":"Neurobiol Dis"},{"key":"2712_CR106","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/bdi.12143","volume":"16","author":"MJ Ostacher","year":"2014","unstructured":"Ostacher MJ, Iosifescu DV, Hay A, Blumenthal SR, Sklar P, Perlis RH (2014) Pilot investigation of isradipine in the treatment of bipolar depression motivated by genome-wide association. Bipolar Disord 16:199\u2013203","journal-title":"Bipolar Disord"},{"key":"2712_CR107","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eplepsyres.2011.01.003","volume":"94","author":"S Ziyatdinova","year":"2011","unstructured":"Ziyatdinova S, Gurevicius K, Kutchiashvili N, Bolkvadze T, Nissinen J, Tanila H, Pitkanen A (2011) Spontaneous epileptiform discharges in a mouse model of Alzheimer\u2019s disease are suppressed by antiepileptic drugs that block sodium channels. Epilepsy Res 94:75\u201385","journal-title":"Epilepsy Res"},{"key":"2712_CR108","first-page":"746","volume":"24","author":"XC Weng","year":"2003","unstructured":"Weng XC, Gai XD, Zheng JQ, Li J (2003) Agmatine blocked voltage-gated calcium channel in cultured rat hippocampal neurons. Acta Pharmacol Sin 24:746\u2013750","journal-title":"Acta Pharmacol Sin"},{"key":"2712_CR109","first-page":"281","volume":"25","author":"JQ Zheng","year":"2004","unstructured":"Zheng JQ, Weng XC, Gai XD, Li J, Xiao WB (2004) Mechanism underlying blockade of voltage-gated calcium channels by agmatine in cultured rat hippocampal neurons. Acta Pharmacol Sin 25:281\u2013285","journal-title":"Acta Pharmacol Sin"},{"key":"2712_CR110","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0006-8993(02)02260-6","volume":"932","author":"G Wang","year":"2002","unstructured":"Wang G, Gorbatyuk OS, Dayanithi G, Ouyang W, Wang J, Milner TA, Regunathan S, Reis DJ (2002) Evidence for endogenous agmatine in hypothalamo-neurohypophysial tract and its modulation on vasopressin release and Ca2+ channels. Brain Res 932:25\u201336","journal-title":"Brain Res"},{"key":"2712_CR111","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.bbrc.2016.06.086","volume":"477","author":"YH Kim","year":"2016","unstructured":"Kim YH, Jeong JH, Ahn DS, Chung S (2016) Agmatine suppresses peripheral sympathetic tone by inhibiting N-type Ca2+ channel activity via imidazoline I2 receptor activation. Biochem Biophys Res Commun 477:406\u2013412","journal-title":"Biochem Biophys Res Commun"},{"key":"2712_CR112","first-page":"288","volume":"3","author":"XP Chu","year":"2011","unstructured":"Chu XP, Papasian CJ, Wang JQ, Xiong ZG (2011) Modulation of acid-sensing ion channels: molecular mechanisms and therapeutic potential. Int J Physiol Pathophysiol Pharmacol 3:288\u2013309","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"2712_CR113","doi-asserted-by":"publisher","first-page":"C699","DOI":"10.1152\/ajpcell.00188.2012","volume":"303","author":"TW Sherwood","year":"2012","unstructured":"Sherwood TW, Frey EN, Askwith CC (2012) Structure and activity of the acid-sensing ion channels. Am J Physiol Cell Physiol 303:C699\u2013C710","journal-title":"Am J Physiol Cell Physiol"},{"key":"2712_CR114","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nature08218","volume":"460","author":"EB Gonzales","year":"2009","unstructured":"Gonzales EB, Kawate T, Gouaux E (2009) Pore architecture and ion sites in acid-sensing ion channels and P2X receptors. Nature 460:599\u2013604","journal-title":"Nature"},{"key":"2712_CR115","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1073\/pnas.032678399","volume":"99","author":"CJ Benson","year":"2002","unstructured":"Benson CJ, Xie J, Wemmie JA, Price MP, Henss JM, Welsh MJ, Snyder PM (2002) Heteromultimers of DEG\/ENaC subunits form H+-gated channels in mouse sensory neurons. Proc Natl Acad Sci USA 99:2338\u20132343","journal-title":"Proc Natl Acad Sci USA"},{"key":"2712_CR116","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nature10607","volume":"479","author":"CJ Bohlen","year":"2011","unstructured":"Bohlen CJ, Chesler AT, Sharif-Naeini R, Medzihradszky KF, Zhou S, King D, Sanchez EE, Burlingame AL, Basbaum AI, Julius D (2011) A heteromeric Texas coral snake toxin targets acid-sensing ion channels to produce pain. Nature 479:410\u2013414","journal-title":"Nature"},{"key":"2712_CR117","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neuron.2010.09.001","volume":"68","author":"Y Yu","year":"2010","unstructured":"Yu Y, Chen Z, Li WG, Cao H, Feng EG, Yu F, Liu H, Jiang H, Xu TL (2010) A nonproton ligand sensor in the acid-sensing ion channel. Neuron 68:61\u201372","journal-title":"Neuron"},{"key":"2712_CR118","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/SLA.0b013e31822645b4","volume":"254","author":"R Hu","year":"2011","unstructured":"Hu R, Duan B, Wang D, Yu Y, Li W, Luo H, Lu P, Lin J, Zhu G, Wan Q, Feng H (2011) Role of acid-sensing ion channel 1a in the secondary damage of traumatic spinal cord injury. Ann Surg 254:353\u2013362","journal-title":"Ann Surg"},{"key":"2712_CR119","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/brain\/awl325","volume":"130","author":"G Pignataro","year":"2007","unstructured":"Pignataro G, Simon RP, Xiong ZG (2007) Prolonged activation of ASIC1a and the time window for neuroprotection in cerebral ischaemia. Brain 130:151\u2013158","journal-title":"Brain"},{"key":"2712_CR120","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0896-6273(02)00661-X","volume":"34","author":"JA Wemmie","year":"2002","unstructured":"Wemmie JA, Chen J, Askwith CC, Hruska-Hageman AM, Price MP, Nolan BC, Yoder PG, Lamani E, Hoshi T, Freeman JH Jr, Welsh MJ (2002) The acid-activated ion channel ASIC contributes to synaptic plasticity, learning, and memory. Neuron 34:463\u2013477","journal-title":"Neuron"},{"key":"2712_CR121","first-page":"88","volume":"6","author":"WG Li","year":"2010","unstructured":"Li WG, Yu Y, Zhang ZD, Cao H, Xu TL (2010) ASIC3 channels integrate agmatine and multiple inflammatory signals through the nonproton ligand sensing domain. Mol Pain 6:88","journal-title":"Mol Pain"},{"key":"2712_CR122","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0028-3908(94)90060-4","volume":"33","author":"SJ Peroutka","year":"1994","unstructured":"Peroutka SJ, Howell TA (1994) The molecular evolution of G protein-coupled receptors: focus on 5-hydroxytryptamine receptors. Neuropharmacology 33:319\u2013324","journal-title":"Neuropharmacology"},{"key":"2712_CR123","first-page":"157","volume":"46","author":"D Hoyer","year":"1994","unstructured":"Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP (1994) International union of pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 46:157\u2013203","journal-title":"Pharmacol Rev"},{"key":"2712_CR124","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pharmthera.2015.01.009","volume":"150","author":"JD McCorvy","year":"2015","unstructured":"McCorvy JD, Roth BL (2015) Structure and function of serotonin G protein-coupled receptors. Pharmacol Ther 150:129\u2013142","journal-title":"Pharmacol Ther"},{"key":"2712_CR125","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1126\/science.1232807","volume":"340","author":"C Wang","year":"2013","unstructured":"Wang C, Jiang Y, Ma J, Wu H, Wacker D, Katritch V, Han GW, Liu W, Huang XP, Vardy E, McCorvy JD, Gao X, Zhou XE, Melcher K, Zhang C, Bai F, Yang H, Yang L, Jiang H, Roth BL, Cherezov V, Stevens RC, Xu HE (2013) Structural basis for molecular recognition at serotonin receptors. Science 340:610\u2013614","journal-title":"Science"},{"key":"2712_CR126","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1503\/jpn.140099","volume":"40","author":"L Booij","year":"2015","unstructured":"Booij L, Tremblay RE, Szyf M, Benkelfat C (2015) Genetic and early environmental influences on the serotonin system: consequences for brain development and risk for psychopathology. J Psychiatry Neurosci 40:5\u201318","journal-title":"J Psychiatry Neurosci"},{"key":"2712_CR127","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0014-2999(03)01735-7","volume":"469","author":"YF Li","year":"2003","unstructured":"Li YF, Gong ZH, Cao JB, Wang HL, Luo ZP, Li J (2003) Antidepressant-like effect of agmatine and its possible mechanism. Eur J Pharmacol 469:81\u201388","journal-title":"Eur J Pharmacol"},{"key":"2712_CR128","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.brainres.2004.07.041","volume":"1023","author":"ADE Zomkowski","year":"2004","unstructured":"Zomkowski ADE, Rosa AO, Lin J, Santos AR, Calixto JB, Rodrigues ALS (2004) Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test. Brain Res 1023:253\u2013263","journal-title":"Brain Res"},{"key":"2712_CR129","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF00171054","volume":"354","author":"GJ Molderings","year":"1996","unstructured":"Molderings GJ, Schmidt K, B\u00f6nisch H (1996) Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of \u03c32 binding sites. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 354:245\u2013252","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"2712_CR130","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1601-5215.2012.00675.x","volume":"25","author":"B Shopsin","year":"2013","unstructured":"Shopsin B (2013) The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study. Acta Neuropsychiatry 25:113\u2013118","journal-title":"Acta Neuropsychiatry"},{"key":"2712_CR131","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1007\/s12035-014-8827-1","volume":"51","author":"AE Freitas","year":"2015","unstructured":"Freitas AE, Egea J, Buendia I, Navarro E, Rada P, Cuadrado A, Rodrigues AL, Lopez MG (2015) Agmatine induces Nrf2 and protects against corticosterone effects in hippocampal neuronal cell line. Mol Neurobiol 51:1504\u20131519","journal-title":"Mol Neurobiol"},{"key":"2712_CR132","first-page":"PL 41","volume":"58","author":"GM Gilad","year":"1996","unstructured":"Gilad GM, Salame K, Rabey JM, Gilad VH (1996) Agmatine treatment is neuroprotective in rodent brain injury models. Life Sci 58:PL 41\u201346","journal-title":"Life Sci"},{"key":"2712_CR133","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0304-3940(00)01625-6","volume":"296","author":"GM Gilad","year":"2000","unstructured":"Gilad GM, Gilad VH (2000) Accelerated functional recovery and neuroprotection by agmatine after spinal cord ischemia in rats. Neurosci Lett 296:97\u2013100","journal-title":"Neurosci Lett"},{"key":"2712_CR134","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2165\/00023210-200721110-00002","volume":"21","author":"A Halaris","year":"2007","unstructured":"Halaris A, Plietz J (2007) Agmatine: metabolic pathway and spectrum of activity in brain. CNS Drugs 21:885\u2013900","journal-title":"CNS Drugs"},{"key":"2712_CR135","first-page":"544","volume":"288","author":"XC Yang","year":"1999","unstructured":"Yang XC, Reis DJ (1999) Agmatine selectively blocks the N-methyl-D-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J Pharmacol Exp Ther 288:544\u2013549","journal-title":"J Pharmacol Exp Ther"},{"key":"2712_CR136","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1097\/00001756-200009280-00031","volume":"11","author":"CG Yu","year":"2000","unstructured":"Yu CG, Marcillo AE, Fairbanks CA, Wilcox GL, Yezierski RP (2000) Agmatine improves locomotor function and reduces tissue damage following spinal cord injury. Neuroreport 11:3203\u20133207","journal-title":"Neuroreport"},{"key":"2712_CR137","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00401-009-0496-1","volume":"117","author":"J Kriz","year":"2009","unstructured":"Kriz J, Lalancette-Hebert M (2009) Inflammation, plasticity and real-time imaging after cerebral ischemia. Acta Neuropathol 117:497\u2013509","journal-title":"Acta Neuropathol"},{"key":"2712_CR138","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.expneurol.2004.05.029","volume":"189","author":"JH Kim","year":"2004","unstructured":"Kim JH, Yenari MA, Giffard RG, Cho SW, Park KA, Lee JE (2004) Agmatine reduces infarct area in a mouse model of transient focal cerebral ischemia and protects cultured neurons from ischemia-like injury. Exp Neurol 189:122\u2013130","journal-title":"Exp Neurol"},{"key":"2712_CR139","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.brainres.2009.05.046","volume":"1281","author":"WT Lee","year":"2009","unstructured":"Lee WT, Hong S, Yoon SH, Kim JH, Park KA, Seong GJ, Lee JE (2009) Neuroprotective effects of agmatine on oxygen-glucose deprived primary-cultured astrocytes and nuclear translocation of nuclear factor-kappa B. Brain Res 1281:64\u201370","journal-title":"Brain Res"},{"key":"2712_CR140","first-page":"780","volume":"27","author":"DJ Kim","year":"2006","unstructured":"Kim DJ, Kim DI, Lee SK, Suh SH, Lee YJ, Kim J, Chung TS, Lee JE (2006) Protective effect of agmatine on a reperfusion model after transient cerebral ischemia: temporal evolution on perfusion MR imaging and histopathologic findings. AJNR Am J Neuroradiol 27:780\u2013785","journal-title":"AJNR Am J Neuroradiol"},{"key":"2712_CR141","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/jcbfm.2009.260","volume":"30","author":"JH Kim","year":"2010","unstructured":"Kim JH, Lee YW, Park KA, Lee WT, Lee JE (2010) Agmatine attenuates brain edema through reducing the expression of aquaporin-1 after cerebral ischemia. J Cereb Blood Flow Metab 30:943\u2013949","journal-title":"J Cereb Blood Flow Metab"},{"key":"2712_CR142","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1179\/016164107X208103","volume":"29","author":"MZ Yang","year":"2007","unstructured":"Yang MZ, Mun CH, Choi YJ, Baik JH, Park KA, Lee WT, Lee JE (2007) Agmatine inhibits matrix metalloproteinase-9 via endothelial nitric oxide synthase in cerebral endothelial cells. Neurol Res 29:749\u2013754","journal-title":"Neurol Res"},{"key":"2712_CR143","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3346\/jkms.2015.30.7.943","volume":"30","author":"JY Kim","year":"2015","unstructured":"Kim JY, Lee YW, Kim JH, Lee WT, Park KA, Lee JE (2015) Agmatine attenuates brain edema and apoptotic cell death after traumatic brain injury. J Korean Med Sci 30:943\u2013952","journal-title":"J Korean Med Sci"},{"key":"2712_CR144","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.resuscitation.2007.05.011","volume":"75","author":"JR Kuo","year":"2007","unstructured":"Kuo JR, Lo CJ, Chio CC, Chang CP, Lin MT (2007) Resuscitation from experimental traumatic brain injury by agmatine therapy. Resuscitation 75:506\u2013514","journal-title":"Resuscitation"},{"key":"2712_CR145","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/01.wnr.0000192739.38653.aa","volume":"17","author":"CJ Goracke-Postle","year":"2006","unstructured":"Goracke-Postle CJ, Nguyen HO, Stone LS, Fairbanks CA (2006) Release of tritiated agmatine from spinal synaptosomes. Neuroreport 17:13\u201317","journal-title":"Neuroreport"},{"key":"2712_CR146","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jcyt.2014.08.006","volume":"17","author":"YM Park","year":"2015","unstructured":"Park YM, Han SH, Seo SK, Park KA, Lee WT, Lee JE (2015) Restorative benefits of transplanting human mesenchymal stromal cells overexpressing arginine decarboxylase genes after spinal cord injury. Cytotherapy 17:25\u201337","journal-title":"Cytotherapy"},{"key":"2712_CR147","doi-asserted-by":"publisher","first-page":"e53911","DOI":"10.1371\/journal.pone.0053911","volume":"8","author":"YM Park","year":"2013","unstructured":"Park YM, Lee WT, Bokara KK, Seo SK, Park SH, Kim JH, Yenari MA, Park KA, Lee JE (2013) The multifaceted effects of agmatine on functional recovery after spinal cord injury through Modulations of BMP-2\/4\/7 expressions in neurons and glial cells. PLoS ONE 8:e53911","journal-title":"PLoS ONE"},{"key":"2712_CR148","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.neuropharm.2016.10.029","volume":"113","author":"S Kang","year":"2017","unstructured":"Kang S, Kim CH, Jung H, Kim E, Song HT, Lee JE (2017) Agmatine ameliorates type 2 diabetes induced-Alzheimer\u2019s disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling. Neuropharmacology 113:467\u2013479","journal-title":"Neuropharmacology"},{"key":"2712_CR149","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1006\/nlme.2002.4076","volume":"78","author":"NS Arteni","year":"2002","unstructured":"Arteni NS, Lavinsky D, Rodrigues AL, Frison VB, Netto CA (2002) Agmatine facilitates memory of an inhibitory avoidance task in adult rats. Neurobiol Learn Mem 78:465\u2013469","journal-title":"Neurobiol Learn Mem"},{"key":"2712_CR150","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.neuroscience.2009.01.039","volume":"159","author":"P Liu","year":"2009","unstructured":"Liu P, Bergin DH (2009) Differential effects of i.c.v. microinfusion of agmatine on spatial working and reference memory in the rat. Neuroscience 159:951\u2013961","journal-title":"Neuroscience"},{"key":"2712_CR151","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.pbb.2010.08.007","volume":"97","author":"W Lu","year":"2010","unstructured":"Lu W, Dong HJ, Gong ZH, Su RB, Li J (2010) Agmatine inhibits morphine-induced memory impairment in the mouse step-down inhibitory avoidance task. Pharmacol Biochem Behav 97:256\u2013261","journal-title":"Pharmacol Biochem Behav"},{"key":"2712_CR152","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejphar.2014.03.041","volume":"736","author":"M Moosavi","year":"2014","unstructured":"Moosavi M, Zarifkar AH, Farbood Y, Dianat M, Sarkaki A, Ghasemi R (2014) Agmatine protects against intracerebroventricular streptozotocin-induced water maze memory deficit, hippocampal apoptosis and Akt\/GSK3\u03b2 signaling disruption. Eur J Pharmacol 736:107\u2013114","journal-title":"Eur J Pharmacol"},{"key":"2712_CR153","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3349\/ymj.2014.55.3.689","volume":"55","author":"J Song","year":"2014","unstructured":"Song J, Hur BE, Bokara KK, Yang W, Cho HJ, Park KA, Lee WT, Lee KM, Lee JE (2014) Agmatine improves cognitive dysfunction and prevents cell death in a streptozotocin-induced Alzheimer rat model. Yonsei Med J 55:689\u2013699","journal-title":"Yonsei Med J"},{"key":"2712_CR154","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.neuroscience.2010.05.004","volume":"169","author":"DH Bergin","year":"2010","unstructured":"Bergin DH, Liu P (2010) Agmatine protects against \u03b2-amyloid25-35-induced memory impairments in the rat. Neuroscience 169:794\u2013811","journal-title":"Neuroscience"},{"key":"2712_CR155","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00726-011-0994-z","volume":"42","author":"S Condello","year":"2012","unstructured":"Condello S, Calabro E, Caccamo D, Curro M, Ferlazzo N, Satriano J, Magazu S, Ientile R (2012) Protective effects of agmatine in rotenone-induced damage of human SH-SY5Y neuroblastoma cells: Fourier transform infrared spectroscopy analysis in a model of Parkinson\u2019s disease. Amino Acids 42:775\u2013781","journal-title":"Amino Acids"},{"key":"2712_CR156","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1471-4159.2010.07085.x","volume":"116","author":"S Condello","year":"2011","unstructured":"Condello S, Curro M, Ferlazzo N, Caccamo D, Satriano J, Ientile R (2011) Agmatine effects on mitochondrial membrane potential and NF-kappaB activation protect against rotenone-induced cell damage in human neuronal-like SH-SY5Y cells. J Neurochem 116:67\u201375","journal-title":"J Neurochem"},{"key":"2712_CR157","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s11064-005-6865-9","volume":"30","author":"GM Gilad","year":"2005","unstructured":"Gilad GM, Gilad VH, Finberg JP, Rabey JM (2005) Neurochemical evidence for agmatine modulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity. Neurochem Res 30:713\u2013719","journal-title":"Neurochem Res"},{"key":"2712_CR158","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0091-3057(02)01079-1","volume":"74","author":"AK Bence","year":"2003","unstructured":"Bence AK, Worthen DR, Stables JP, Crooks PA (2003) An in vivo evaluation of the antiseizure activity and acute neurotoxicity of agmatine. Pharmacol Biochem Behav 74:771\u2013775","journal-title":"Pharmacol Biochem Behav"},{"key":"2712_CR159","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00702-008-0046-3","volume":"115","author":"JJ Luszczki","year":"2008","unstructured":"Luszczki JJ, Czernecki R, Wojtal K, Borowicz KK, Czuczwar SJ (2008) Agmatine enhances the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock seizure model. J Neural Transm 115:1485\u20131494","journal-title":"J Neural Transm"},{"key":"2712_CR160","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.yebeh.2010.04.014","volume":"18","author":"A Bahremand","year":"2010","unstructured":"Bahremand A, Ziai P, Khodadad TK, Payandemehr B, Rahimian R, Ghasemi A, Ghasemi M, Hedayat T, Dehpour AR (2010) Agmatine enhances the anticonvulsant effect of lithium chloride on pentylenetetrazole-induced seizures in mice: involvement of L-arginine\/nitric oxide pathway. Epilepsy Behav 18:186\u2013192","journal-title":"Epilepsy Behav"},{"key":"2712_CR161","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.eplepsyres.2005.04.003","volume":"65","author":"K Riazi","year":"2005","unstructured":"Riazi K, Honar H, Homayoun H, Rashidi N, Kiani S, Ebrahimkhani MR, Noorian AR, Ghaffari K, Jannati A, Dehpour AR (2005) The synergistic anticonvulsant effect of agmatine and morphine: possible role of alpha 2-adrenoceptors. Epilepsy Res 65:33\u201340","journal-title":"Epilepsy Res"},{"key":"2712_CR162","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.yebeh.2011.07.002","volume":"22","author":"L Moezi","year":"2011","unstructured":"Moezi L, Shafaroodi H, Hojati A, Dehpour AR (2011) The interaction of melatonin and agmatine on pentylenetetrazole-induced seizure threshold in mice. Epilepsy Behav 22:200\u2013206","journal-title":"Epilepsy Behav"},{"key":"2712_CR163","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.pbb.2003.11.016","volume":"77","author":"RB Su","year":"2004","unstructured":"Su RB, Wei XL, Zheng JQ, Liu Y, Lu XQ, Li J (2004) Anticonvulsive effect of agmatine in mice. Pharmacol Biochem Behav 77:345\u2013349","journal-title":"Pharmacol Biochem Behav"},{"key":"2712_CR164","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3892\/etm.2014.1711","volume":"8","author":"H Xu","year":"2014","unstructured":"Xu H, Ou F, Wang P, Naren M, Tu D, Zheng R (2014) High dosage of agmatine alleviates pentylenetetrazole-induced chronic seizures in rats possibly by exerting an anticonvulsive effect. Exp Ther Med 8:73\u201378","journal-title":"Exp Ther Med"},{"key":"2712_CR165","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00702-017-1836-2","volume":"125","author":"E Esnafoglu","year":"2018","unstructured":"Esnafoglu E, Irende I (2018) Decreased plasma agmatine levels in autistic subjects. J Neural Transm 125:735\u2013740","journal-title":"J Neural Transm"},{"key":"2712_CR166","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neuropharm.2016.09.014","volume":"113","author":"JW Kim","year":"2017","unstructured":"Kim JW, Seung H, Kim KC, Gonzales ELT, Oh HA, Yang SM, Ko MJ, Han SH, Banerjee S, Shin CY (2017) Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism. Neuropharmacology 113:71\u201381","journal-title":"Neuropharmacology"},{"key":"2712_CR167","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jpsychires.2013.04.004","volume":"47","author":"T Uzbay","year":"2013","unstructured":"Uzbay T, Goktalay G, Kayir H, Eker SS, Sarandol A, Oral S, Buyukuysal L, Ulusoy G, Kirli S (2013) Increased plasma agmatine levels in patients with schizophrenia. J Psychiatr Res 47:1054\u20131060","journal-title":"J Psychiatr Res"},{"key":"2712_CR168","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1177\/0269881109102533","volume":"24","author":"T Uzbay","year":"2010","unstructured":"Uzbay T, Kayir H, Goktalay G, Yildirim M (2010) Agmatine disrupts prepulse inhibition of acoustic startle reflex in rats. J Psychopharmacol 24:923\u2013929","journal-title":"J Psychopharmacol"},{"key":"2712_CR169","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.pbb.2011.09.006","volume":"100","author":"NR Kotagale","year":"2012","unstructured":"Kotagale NR, Taksande BG, Wadhwani PJ, Palhade MW, Mendhi SM, Gawande DY, Hadole PN, Chopde CT (2012) Psychopharmacological study of agmatine in behavioral tests of schizophrenia in rodents. Pharmacol Biochem Behav 100:398\u2013403","journal-title":"Pharmacol Biochem Behav"},{"key":"2712_CR170","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ejphar.2008.06.022","volume":"590","author":"E Palsson","year":"2008","unstructured":"Palsson E, Fejgin K, Wass C, Klamer D (2008) Agmatine attenuates the disruptive effects of phencyclidine on prepulse inhibition. Eur J Pharmacol 590:212\u2013216","journal-title":"Eur J Pharmacol"},{"key":"2712_CR171","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejphar.2015.11.044","volume":"770","author":"NB Gawali","year":"2016","unstructured":"Gawali NB, Chowdhury AA, Kothavade PS, Bulani VD, Nagmoti DM, Juvekar AR (2016) Involvement of nitric oxide in anticompulsive-like effect of agmatine on marble-burying behaviour in mice. Eur J Pharmacol 770:165\u2013171","journal-title":"Eur J Pharmacol"},{"key":"2712_CR172","first-page":"2048","volume":"5","author":"VMSFR Patel","year":"2014","unstructured":"Patel VMSFR (2014) Agmatine ameliorates social isolation induced obsessive-compulsive behavior in mice. J Glob Trends Pharm Sci 5:2048\u20132051","journal-title":"J Glob Trends Pharm Sci"},{"key":"2712_CR173","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/ijnp\/pyy058","volume":"21","author":"GG Chen","year":"2018","unstructured":"Chen GG, Almeida D, Fiori L, Turecki G (2018) Evidence of reduced agmatine concentrations in the cerebral cortex of suicides. Int J Neuropsychopharmacol 21:895\u2013900","journal-title":"Int J Neuropsychopharmacol"},{"key":"2712_CR174","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.brainres.2017.03.004","volume":"1663","author":"NB Gawali","year":"2017","unstructured":"Gawali NB, Bulani VD, Gursahani MS, Deshpande PS, Kothavade PS, Juvekar AR (2017) Agmatine attenuates chronic unpredictable mild stress-induced anxiety, depression-like behaviours and cognitive impairment by modulating nitrergic signalling pathway. Brain Res 1663:66\u201377","journal-title":"Brain Res"},{"key":"2712_CR175","doi-asserted-by":"publisher","first-page":"e852","DOI":"10.1038\/tp.2016.116","volume":"6","author":"EM Meylan","year":"2016","unstructured":"Meylan EM, Breuillaud L, Seredenina T, Magistretti PJ, Halfon O, Luthi-Carter R, Cardinaux JR (2016) Involvement of the agmatinergic system in the depressive-like phenotype of the Crtc1 knockout mouse model of depression. Transl Psychiatry 6:e852","journal-title":"Transl Psychiatry"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-018-02712-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-018-02712-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-018-02712-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T19:26:51Z","timestamp":1578079611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-018-02712-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,4]]},"references-count":175,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["2712"],"URL":"https:\/\/doi.org\/10.1007\/s11064-018-02712-1","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,4]]},"assertion":[{"value":"15 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}